Across TCGA pan-cancer cohorts, TRAPPC2P3 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated TRAPPC2P3 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher TRAPPC2P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAPPC2P3 expression acts as an unfavorable survival marker.

ESCA and STAD are the cancer types where TRAPPC2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.211	0.876	.028	27	view →
STAD	DFS	Tertile	III,IV	0.419	0.583	.030	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TRAPPC2P3 tumor-vs-normal RNA expression · all TRAPPC2P3 data types